<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29087" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Skin Antiseptics</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bednarek</surname>
            <given-names>Robert S.</given-names>
          </name>
          <aff>Geisinger</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nassereddin</surname>
            <given-names>Ali</given-names>
          </name>
          <aff>WakeMed Health and Hospitals</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramsey</surname>
            <given-names>Michael L.</given-names>
          </name>
          <aff>Geisinger Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Bednarek declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ali Nassereddin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Ramsey declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29087.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Antiseptics are chemical agents applied to the skin to reduce the microbial count and reduce the risk of surgical site infections (SSIs). SSIs are defined as an infection occurring at the surgical site within 30 days of the procedure and represent one of the most common complications of dermatologic surgery. Broad-spectrum antiseptics generally cover more pathogens and subsequently are some of the most popular in dermatologic surgery. Antiseptic agents in dermatologic surgery commonly include chlorhexidine, povidone-iodine, chloroxylenol, isopropyl alcohol, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. They should be used for most, if not all, procedures that enter the dermis of the skin or deeper. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, and monitoring of skin antiseptics, so providers can direct patient therapy where they are indicated as part of the interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the mechanisms of action of some of the common dermal antiseptic agents.</p></list-item><list-item><p>Review the indications for using dermal antiseptics.</p></list-item><list-item><p>Summarize the potential adverse events of various skin antiseptic agents.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance care delivery for patients who can benefit from dermal antiseptic agents.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29087&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29087">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29087.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Antiseptics are chemical agents applied to the skin to reduce the microbial count and the risk of surgical site infections (SSIs). SSIs are defined as an infection occurring at the surgical site within 30 days of a&#x000a0;procedure and represent one of the most common complications of dermatologic surgery.<xref ref-type="bibr" rid="article-29087.r1">[1]</xref> The use of antiseptics dates back to the mid-1800s when Ignaz Semmelweis noted a dramatic decrease in periportal sepsis events with appropriate handwashing techniques, later reaffirmed with Lister&#x02019;s use of carbolic acid, showing improved infection control and reduction in surgical morbidity. Antiseptic agents in dermatologic surgery commonly include chlorhexidine, povidone-iodine, chloroxylenol, isopropyl alcohol, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. They should be used for most, if not all, procedures that enter the dermis of the skin or deeper.<xref ref-type="bibr" rid="article-29087.r2">[2]</xref></p>
      </sec>
      <sec id="article-29087.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Each antiseptic possesses a specific mechanism of action, the spectrum of microbes targeted, and a side-effect profile that the surgeon should carefully weigh before selecting the agent for&#x000a0;the procedure. Other factors to consider when selecting an optimal surgical scrub include the patient's underlying health status, the expected extent of surgery, the anatomic location of the tumor, and the planned reconstruction. Particularly related to the skin, the most common pathogens implicated in SSIs are <italic toggle="yes">Staphylococcus aureus</italic>, followed by other gram-positive bacteria, including coagulase-negative <italic toggle="yes">Staphylococcus</italic>, <italic toggle="yes">Enterococcus</italic>, and group A <italic toggle="yes">Streptococci.&#x000a0;</italic>Other implicated bacteria are gram-negative rods, particularly <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Pseudomonas</italic>. Broad-spectrum antiseptics generally cover more pathogens and subsequently are some of the most popular in dermatologic surgery.<xref ref-type="bibr" rid="article-29087.r3">[3]</xref></p>
        <p>
<bold>Chlorhexidine</bold>
</p>
        <p>Chlorhexidine is a positively charged biguanide at physiologic pH that binds to bacteria's negatively charged cell walls, disrupting microbial cell membranes and precipitation of cell contents. At low concentrations, it is bacteriostatic, but at higher concentrations, it is bactericidal. Chlorhexidine displays a wide range of coverage, including gram-positive and gram-negative bacteria, fungi, enveloped viruses, and<italic toggle="yes"> Mycobacterial tuberculosis</italic>. Advantages include its broad-spectrum, fast onset of action, and excellent sustained/residual activity after being wiped from the field via binding to the stratum corneum.&#x000a0;It is an extensively used antiseptic in&#x000a0;dentistry&#x000a0;but at a much lower concentration (concentrations of 0.12% to 0.2% are recommended).<xref ref-type="bibr" rid="article-29087.r4">[4]</xref></p>
        <p>
<bold>Povidone-Iodine</bold>
</p>
        <p>Povidone-iodine is a complex of povidone, hydrogen iodide, and elemental iodine. It is thought to act via iodination (a form of halogenation) to oxidize lipids of the cell membrane and form salts with microbial proteins. Povidone-iodine is a broad-coverage antiseptic with microbicidal activity against gram-positive and gram-negative bacteria (including spores and <italic toggle="yes">M. tuberculosis</italic>), fungi, viruses, and protozoa. Additionally, this antimicrobial acts rapidly after application to the skin but has minimal residual activity, unlike chlorhexidine.&#x000a0;In one study, as a facial antiseptic, it was considered a safer alternative to chlorhexidine.<xref ref-type="bibr" rid="article-29087.r5">[5]</xref></p>
        <p>
<bold>Chloroxylenol</bold>
</p>
        <p>Chloroxylenol is a halophenol that is thought to act by microbial cell wall disruption and inactivation of cellular enzymes. It is likely bactericidal with broad coverage of gram-positive and gram-negative bacteria but less activity against <italic toggle="yes">M. tuberculosis</italic>, fungi, and viruses. Chloroxylenol is fairly slow-acting and has a minimal residual effect; despite this, it has shown a similar incidence of SSIs as chlorhexidine in a recent study.</p>
        <p>
<bold>Isopropyl Alcohol</bold>
</p>
        <p>Isopropyl alcohol is hydrophilic alcohol that likely causes membrane damage and denatures proteins needed for microbial metabolism and growth. Isopropyl alcohol is typically mixed with water because the microbial activity is greatest in a 60% to 90% solution rather than in the pure form or lower concentrations. Generally, alcohol solutions are thought to have most of their activity against gram-positive bacteria (bactericidal) but may have minor activity against some viruses and fungi. While one of the weaker cleansing agents with minimal residual activity, it has the fastest onset of action of antiseptics.</p>
        <p>
<bold>Hexachlorophene</bold>
</p>
        <p>Hexachlorophene is a bisphenol compound that primarily acts by inhibiting the membrane-bound portion of the electron transport chain and disrupting microbial cell membranes. At concentrations used in skin-cleansing agents, it is bacteriostatic and is primarily only active against gram-positive cocci, with little activity against gram-negative organisms and no fungal coverage. Hexachlorophene has the advantage of having a residual activity for several hours after use and gradually reduces bacterial counts after multiple uses (cumulative effect). Newer agents with broader antimicrobial coverage and fewer side effects have largely replaced hexachlorophene as a surgical scrub.</p>
        <p>
<bold>Benzalkonium Chloride</bold>
</p>
        <p>Benzalkonium chloride is a quaternary ammonium detergent (also called a cationic surfactant) that acts by irreversibly binding to phospholipids and proteins of the membrane, disrupting the cell membrane. It acts as a bactericide against many gram-positive and gram-negative bacteria but has inconsistent coverage against fungi, viruses, and mycobacteria. The advantages of benzalkonium are its stability and ability to be applied with a low incidence of irritant contact dermatitis. Like hexachlorophene, benzalkonium has been replaced by antiseptics with better antimicrobial coverage.</p>
        <p>
<bold>Hydrogen Peroxide</bold>
</p>
        <p>Hydrogen peroxide is the simplest peroxide that forms highly reactive free radicals (hydroxyl radicals) that attack and oxidize essential cell components, including lipids, proteins, and nucleic acids. Although generally better against gram-positive bacteria, hydrogen peroxide also has a microbicidal effect on gram-negative bacteria, bacterial spores, fungi, and viruses&#x000a0;with higher concentrations and longer contact times. In addition to its being a broad-spectrum agent, it has a rapid onset of action and low cost,&#x000a0;which made it an attractive option in the past. While a common at-home remedy, the evidence argues against routine use as a surgical scrub or cleansing agent due to known cytotoxicity to keratinocytes.<xref ref-type="bibr" rid="article-29087.r6">[6]</xref></p>
      </sec>
      <sec id="article-29087.s4" sec-type="Administration">
        <title>Administration</title>
        <p>All of the discussed antiseptics are administered topically onto the skin surface. However, the application may differ depending on the antiseptic, concentration, and/or formulation. The two most widely administered antiseptic surgical scrub agents in dermatologic surgery are chlorhexidine and povidone-iodine.</p>
        <p>Chlorhexidine-based scrubs are generally composed of 0.5% to 4% chlorhexidine in alcohol or aqueous base typically combined with detergent. Recent evidence suggests that it provides a bactericidal activity for 24 hours after a 2-minute application, making it a useful antiseptic for anticipated long procedures. However, as chlorhexidine can cause irreversible keratitis and middle ear ototoxicity (with sensorineural deafness), topical administration is relatively contraindicated for skin preparation involving or adjacent to the eye and conchal bowl.<xref ref-type="bibr" rid="article-29087.r5">[5]</xref>&#x000a0;</p>
        <p>Chloroxylenol 3% surgical scrub solution may be safely substituted and used for these areas.&#x000a0;Chlorhexidine gluconate (CHG) is a commonly used antiseptic recommended by the Centers for Disease Control for skin cleansing before central venous catheter insertion in adults and children. Current guidelines do not recommend using CHG as an antiseptic in neonates due to a lack of sufficient safety data in premature infants. However, chlorhexidine is commonly used worldwide for off-label indications in neonatal intensive care units (NICU).<xref ref-type="bibr" rid="article-29087.r7">[7]</xref></p>
        <p>Povidone-iodine scrubs are composed of 7.5% to 10.0% povidone-iodine, typically in an aqueous or alcohol base, and are occasionally combined with detergent. The scrub is painted on a clean skin surface and allowed to dry. The product must dry to be bactericidal with a preferred minimum of 2 minutes drying time, although the latter can vary depending on the product used as the scrub. Clinicians can safely use povidone-iodine aqueous scrubs near the eye and conchal bowl.</p>
        <p>Given the advantages of chlorhexidine and povidone-iodine, other antiseptics are used less often or are primarily historical in dermatologic surgery. Briefly, isopropyl alcohol comes as a solution and is often used as a swab to cleanse the skin before a biopsy. Hexachlorophene scrub is an emulsion, while benzalkonium and hydrogen peroxide are both solutions. All are primarily historical with regards to antisepsis in dermatologic surgery.<xref ref-type="bibr" rid="article-29087.r8">[8]</xref><xref ref-type="bibr" rid="article-29087.r9">[9]</xref></p>
      </sec>
      <sec id="article-29087.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>While generally tolerated well, adverse effects of antiseptic agents should be carefully weighed before selection to avoid unwanted complications.</p>
        <p>Chlorhexidine can cause permanent keratitis, conjunctivitis, and permanent sensorineural deafness (entrance to the middle ear via hole/tear of the tympanic membrane). Chronic use can cause irritant contact dermatitis, and it is reportedly a rare contact allergen.<xref ref-type="bibr" rid="article-29087.r5">[5]</xref><xref ref-type="bibr" rid="article-29087.r10">[10]</xref></p>
        <p>Povidone-iodine can stain the skin, hair, and clothing. Severe irritant contact dermatitis can be invoked when left on the skin for prolonged periods. It is a known contact allergen that can cross-react with iodides in medications and radiopaque iodine. Microbicidal activity is lost when povidone-iodine comes into contact with blood or sputum. There are also reports of neonatal hypothyroidism with chronic maternal use via percutaneous absorption of the iodides, causing a Wolff-Chaikoff effect in newborns.<xref ref-type="bibr" rid="article-29087.r11">[11]</xref></p>
        <p>Isopropyl alcohol can induce irritant contact dermatitis and is inflammable in the setting of electrocautery.</p>
        <p>Hexachlorophene was largely removed from the market after it was linked to the deaths of multiple people via neurotoxicity and brain damage. Additionally, percutaneous absorption can also cause teratogenic effects in the fetuses of pregnant women.</p>
        <p>Benzalkonium chloride can cause ocular toxicity and allergic contact dermatitis. While generally considered less irritating to tissues, it has also been shown to cause irritant contact dermatitis with prolonged skin exposure. Anionic compounds such as soap rapidly inactivate benzalkonium chloride.<xref ref-type="bibr" rid="article-29087.r12">[12]</xref><xref ref-type="bibr" rid="article-29087.r13">[13]</xref></p>
        <p>Contact allergy to chloroxylenol is increasingly becoming&#x000a0;a recognized problem with its increased prevalence as a product preservative, in addition to its known irritant effects.<xref ref-type="bibr" rid="article-29087.r14">[14]</xref></p>
        <p>Hydrogen peroxide is cytotoxic to keratinocytes in culture and presumably can impede the reepithelialization of wounds. In addition, it has a bleaching action that can whiten skin, hair, nails, and clothes.</p>
      </sec>
      <sec id="article-29087.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Chlorhexidine may cause a severe allergic reaction. Symptoms may include wheezing, rash, facial swelling, and anaphylactic shock. Use is contraindicated in patients with a history of allergy to chlorhexidine.<xref ref-type="bibr" rid="article-29087.r15">[15]</xref><xref ref-type="bibr" rid="article-29087.r16">[16]</xref></p>
        <p>Povidone-iodine in individuals known to be allergic to iodine or product ingredients is contraindicated.</p>
        <p>Isopropyl alcohol: In June 2020, the FDA issued warnings about methanol or 1-propanol contaminated hand sanitizer brands. Exposure to methanol, including dermally, can cause kidney damage, blindness, and death. Exposure to 1-propanol can cause severe acidosis and death. Chronic exposure may be more likely due to increased hand sanitizer use in 2020. In addition, FDA is warning that symptoms such as dizziness, nausea, headache, and nausea may occur after using alcohol-based hand sanitizers, likely due to breathing in the vapors. Hence always use hand sanitizer in a well-ventilated area.<xref ref-type="bibr" rid="article-29087.r17">[17]</xref></p>
        <p>Hexachlorophene: The Code of Federal Regulations (CFR-21) FDA (Revised 2022) states that hexachlorophene is contraindicated on burned or denuded skin or mucous membranes and as an agent for prophylactic total body bathing. Additionally, FDA noted that although hexachlorophene is a useful bacteriostatic agent, safety concerns have been reported, such as Letterer&#x02013;Siwe disease, neurotoxicity, and death. Hence, hexachlorophene-containing products will be&#x000a0;considered misbranded and subject to regulatory proceedings.</p>
        <p>Clinical Studies and regulatory agencies, including the FDA and EMA, agree that benzalkonium chloride is not innocuous, even when used in small concentrations.<xref ref-type="bibr" rid="article-29087.r18">[18]</xref></p>
      </sec>
      <sec id="article-29087.s7" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Chlorhexidine Gluconate: According to product labeling, chlorhexidine gluconate (4%) may cause serious injury if placed or kept in the eye during surgical procedures or cause deafness when instilled in the middle ear through perforated eardrums. In case of accidental exposure, wash the contact area thoroughly with water.&#x000a0;</p>
        <p>Povidone-iodine: Allergic contact dermatitis has been reported with exposure to povidone-iodine.<xref ref-type="bibr" rid="article-29087.r19">[19]</xref></p>
        <p>Hexachlorophene: The Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List includes hexachlorophene because of strong evidence of neurotoxicity.<xref ref-type="bibr" rid="article-29087.r20">[20]</xref></p>
        <p>Isopropyl Alcohol: The significant features of severe poisoning with isopropyl alcohol are CNS, respiratory depression, and circulatory collapse. The most common metabolic effects are an increased osmol gap, ketonemia, and ketonuria. Diagnosis is confirmed based on the patient's history, clinical presentation, and laboratory investigations. Supportive care is the mainstay of management, emphasizing respiratory and cardiovascular support. Hemodialysis enhances the elimination of isopropyl alcohol and should be considered in severe poisoning.<xref ref-type="bibr" rid="article-29087.r21">[21]</xref></p>
      </sec>
      <sec id="article-29087.s8" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Antiseptic agents in dermatologic surgery commonly include chlorhexidine, povidone-iodine, chloroxylenol, isopropyl alcohol, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. All&#x000a0;interprofessional healthcare team members should be familiar&#x000a0;with skin antiseptics as essential to preventing SSIs. Cleaning wounds, preparing skin for incisional procedures, dressing wounds, or post-surgical wounds appropriately involves an interprofessional team approach of nurses and clinicians&#x000a0;to achieve the best results.&#x000a0;</p>
        <p>In 2013, FDA requested label changes and single-use packaging for OTC topical antiseptic products to reduce the risk of infection. Topical antiseptics are safe and effective agents for patient preoperative or preinjection skin preparation when appropriately used. To decrease the odds of patient infection, ensure these products are used according to the recommendations on the label. Topical antiseptics packaged in single-use containers intended for preoperative use should only be applied at one time to one patient. Nurses should ensure that applicators and unused solutions must be discarded after an individual use. Topical antiseptic agents must not be diluted after opening. Consider topical antiseptics as a potential source of infection when deciding the cause of postoperative infections.<xref ref-type="bibr" rid="article-29087.r22">[22]</xref></p>
        <p>In 2017 FDA, issued a rule specifying that particular active ingredients used in over-the-counter antiseptics intended for use by healthcare professionals in a hospital environment or other healthcare situations outside the hospital are not commonly recognized as safe and effective (GRAS/GRAE).<xref ref-type="bibr" rid="article-29087.r23">[23]</xref>&#x000a0;After reviewing the previous efficacy and safety data of commonly used antiseptics, an innovative approach was needed. This innovative approach, in turn, would reduce the risk of a serious allergic reaction, enhance clinical efficacy, and reduce the risk of irritation of current perioperative antiseptics. Hence a phase 3 trial was carried out. It demonstrated that a combination of 2% chlorhexidine and 70% isopropyl alcohol preparation was efficacious in significantly diminishing the microbial burden without any major adverse events.<xref ref-type="bibr" rid="article-29087.r24">[24]</xref>&#x000a0;[Level 5]</p>
        <p>When using topical antiseptics, all healthcare professionals should carefully choose the agent based on antiseptic coverage, the expected extent of surgery, the anatomic location of the tumor,&#x000a0; the planned reconstruction, and the patient's clinical needs. Open communication and collaborative work of&#x000a0;surgeons, other clinical staff (MDs, DOs, NPs, and PAs), nursing staff, and pharmacists provide the safe and effective use of antiseptic agents for better treatment outcomes.</p>
      </sec>
      <sec id="article-29087.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29087&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29087">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29087/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29087">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29087.s10">
        <title>References</title>
        <ref id="article-29087.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Owens</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Stoessel</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Surgical site infections: epidemiology, microbiology and prevention.</article-title>
            <source>J Hosp Infect</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>70 Suppl 2</volume>
            <fpage>3</fpage>
            <page-range>3-10</page-range>
            <pub-id pub-id-type="pmid">19022115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Echols</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Graves</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>LeBlanc</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Marzolf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yount</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Role of antiseptics in the prevention of surgical site infections.</article-title>
            <source>Dermatol Surg</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>667</fpage>
            <page-range>667-76</page-range>
            <pub-id pub-id-type="pmid">25984901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maris</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Modes of action of disinfectants.</article-title>
            <source>Rev Sci Tech</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-55</page-range>
            <pub-id pub-id-type="pmid">7548971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poppolo Deus</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ouanounou</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects.</article-title>
            <source>Int Dent J</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>269</fpage>
            <page-range>269-277</page-range>
            <pub-id pub-id-type="pmid">35287956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinsapir</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Chlorhexidine Keratitis: Safety of Chlorhexidine as a Facial Antiseptic.</article-title>
            <source>Dermatol Surg</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">27399954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonnell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Antiseptics and disinfectants: activity, action, and resistance.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-79</page-range>
            <pub-id pub-id-type="pmid">9880479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanzi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pitaro</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Skin Injuries and Chlorhexidine Gluconate-Based Antisepsis in Early Premature Infants: A Case Report and Review of the Literature.</article-title>
            <source>J Perinat Neonatal Nurs</source>
            <year>2018</year>
            <season>Oct/Dec</season>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-350</page-range>
            <pub-id pub-id-type="pmid">29782437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schlessinger</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Weil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iyengar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Poon</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Association of Different Surgical Sterile Prep Solutions With Infection Risk After Cutaneous Surgery of the Head and Neck.</article-title>
            <source>JAMA Dermatol</source>
            <year>2017</year>
            <month>Aug</month>
            <day>01</day>
            <volume>153</volume>
            <issue>8</issue>
            <fpage>830</fpage>
            <page-range>830-831</page-range>
            <pub-id pub-id-type="pmid">28538967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darouiche</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Wall</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Itani</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Otterson</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Carrick</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Awad</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Crosby</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Mosier</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Alsharif</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis.</article-title>
            <source>N Engl J Med</source>
            <year>2010</year>
            <month>Jan</month>
            <day>07</day>
            <volume>362</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-26</page-range>
            <pub-id pub-id-type="pmid">20054046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Opstrup</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Johansen</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Zachariae</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garvey</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Contact allergy to chlorhexidine in a tertiary dermatology clinic in Denmark.</article-title>
            <source>Contact Dermatitis</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-36</page-range>
            <pub-id pub-id-type="pmid">26560642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lachapelle</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Allergic contact dermatitis from povidone-iodine: a re-evaluation study.</article-title>
            <source>Contact Dermatitis</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-10</page-range>
            <pub-id pub-id-type="pmid">15701122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Flexural allergic contact dermatitis to benzalkonium chloride in antiseptic bath oil.</article-title>
            <source>Br J Dermatol</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>157</volume>
            <issue>4</issue>
            <fpage>795</fpage>
            <page-range>795-8</page-range>
            <pub-id pub-id-type="pmid">17714561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baudouin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Labb&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pauly</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brignole-Baudouin</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Preservatives in eyedrops: the good, the bad and the ugly.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>312</fpage>
            <page-range>312-34</page-range>
            <pub-id pub-id-type="pmid">20302969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mowad</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chloroxylenol.</article-title>
            <source>Dermatitis</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-1</page-range>
            <pub-id pub-id-type="pmid">17498419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beaudouin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kanny</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Morisset</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Renaudin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mertes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laxenaire</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mouton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jacson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moneret-Vautrin</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Immediate hypersensitivity to chlorhexidine: literature review.</article-title>
            <source>Eur Ann Allergy Clin Immunol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>123</fpage>
            <page-range>123-6</page-range>
            <pub-id pub-id-type="pmid">15180352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Huda</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Chlorhexidine anaphylaxis: implications for post-resuscitation management.</article-title>
            <source>Anaesthesia</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>242</fpage>
            <page-range>242-3</page-range>
            <pub-id pub-id-type="pmid">26750419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCulley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mentari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Diak</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>Michele</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Alcohol-based hand sanitizer exposures and effects on young children in the U.S. during the COVID-19 pandemic.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-356</page-range>
            <pub-id pub-id-type="pmid">32852232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merchel Piovesan Pereira</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tagkopoulos</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Benzalkonium Chlorides: Uses, Regulatory Status, and Microbial Resistance.</article-title>
            <source>Appl Environ Microbiol</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>85</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">31028024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanhoutte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goossens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gilissen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huygens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vital-Durand</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dendooven</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aerts</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Concomitant contact-allergic reactions to iodopropynyl butylcarbamate and iodine.</article-title>
            <source>Contact Dermatitis</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>81</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-23</page-range>
            <pub-id pub-id-type="pmid">30663063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyers</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Thackray</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Matson</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>McPherson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lubsch</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hellinga</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hoff</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title><italic>K</italic>ey Potentially <italic>I</italic>nappropriate <italic>D</italic>rugs in Pediatrics: The KIDs List.</article-title>
            <source>J Pediatr Pharmacol Ther</source>
            <year>2020</year>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-191</page-range>
            <pub-id pub-id-type="pmid">32265601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slaughter</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Beasley</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Schep</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Isopropanol poisoning.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>470</fpage>
            <page-range>470-8</page-range>
            <pub-id pub-id-type="pmid">24815348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <article-title>FDA drug safety communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>i</fpage>
            <page-range>i-ii</page-range>
            <pub-id pub-id-type="pmid">24571007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <collab>Food and Drug Administration, HHS.</collab>
            <article-title>Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final rule.</article-title>
            <source>Fed Regist</source>
            <year>2017</year>
            <month>Dec</month>
            <day>20</day>
            <volume>82</volume>
            <issue>242</issue>
            <fpage>60474</fpage>
            <page-range>60474-503</page-range>
            <pub-id pub-id-type="pmid">29260839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29087.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edmiston</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borlaug</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Seabrook</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Leaper</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Antiseptic efficacy of an innovative perioperative surgical skin preparation: A confirmatory FDA phase 3 analysis.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>653</fpage>
            <page-range>653-659</page-range>
            <pub-id pub-id-type="pmid">32131912</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
